291 related articles for article (PubMed ID: 28432734)
1. Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia.
Astuti D; Sabir A; Fulton P; Zatyka M; Williams D; Hardy C; Milan G; Favaretto F; Yu-Wai-Man P; Rohayem J; López de Heredia M; Hershey T; Tranebjaerg L; Chen JH; Chaussenot A; Nunes V; Marshall B; McAfferty S; Tillmann V; Maffei P; Paquis-Flucklinger V; Geberhiwot T; Mlynarski W; Parkinson K; Picard V; Bueno GE; Dias R; Arnold A; Richens C; Paisey R; Urano F; Semple R; Sinnott R; Barrett TG
Hum Mutat; 2017 Jul; 38(7):764-777. PubMed ID: 28432734
[TBL] [Abstract][Full Text] [Related]
2. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
[TBL] [Abstract][Full Text] [Related]
3. Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.
Katipoğlu N; Karapinar TH; Demir K; Aydin Köker S; Nalbantoğlu Ö; Ay Y; Korkmaz HA; Oymak Y; Yıldız M; Tunç S; Hazan F; Vergin C; Ozkan B
Arch Argent Pediatr; 2017 Jun; 115(3):e153-e156. PubMed ID: 28504500
[TBL] [Abstract][Full Text] [Related]
4. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337
[TBL] [Abstract][Full Text] [Related]
7. A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.
Xian X; Liao L; Shu W; Li H; Qin Y; Yan J; Luo J; Lin FQ
Cell Physiol Biochem; 2018; 47(5):1989-1997. PubMed ID: 29969779
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Habeb AM; Flanagan SE; Zulali MA; Abdullah MA; Pomahačová R; Boyadzhiev V; Colindres LE; Godoy GV; Vasanthi T; Al Saif R; Setoodeh A; Haghighi A; Haghighi A; Shaalan Y; ; Hattersley AT; Ellard S; De Franco E
Diabetologia; 2018 May; 61(5):1027-1036. PubMed ID: 29450569
[TBL] [Abstract][Full Text] [Related]
9. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
[TBL] [Abstract][Full Text] [Related]
11. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
[TBL] [Abstract][Full Text] [Related]
12. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
[TBL] [Abstract][Full Text] [Related]
13. Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.
Setoodeh A; Haghighi A; Saleh-Gohari N; Ellard S; Haghighi A
Gene; 2013 May; 519(2):295-7. PubMed ID: 23454484
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision.
Gruber N; Pinhas-Hamiel O
Curr Diab Rep; 2022 Sep; 22(9):423-432. PubMed ID: 35789979
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM
AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974
[TBL] [Abstract][Full Text] [Related]
17. 50 Years Ago in The Journal of Pediatrics: Thiamine-Responsive Megaloblastic Anemia.
Mullikin D; Grimes AB
J Pediatr; 2019 Apr; 207():53. PubMed ID: 30922504
[No Abstract] [Full Text] [Related]
18. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
[TBL] [Abstract][Full Text] [Related]
19. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Wu S; Yuan Z; Sun Z; Yao F; Sui R
Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
[TBL] [Abstract][Full Text] [Related]
20. Thiamine responsive megaloblastic anemia with a novel SLC19A2 mutation presenting with myeloid maturational arrest.
Dua V; Yadav SP; Kumar V; Khan AA; Puri R; Verma I; Flanagan SE; Ellard S; Sachdeva A
Pediatr Blood Cancer; 2013 Jul; 60(7):1242-3. PubMed ID: 23512295
[No Abstract] [Full Text] [Related]
[Next] [New Search]